The Chemours Company (NYSE:CC – Get Free Report)’s share price gapped down prior to trading on Wednesday after BMO Capital Markets lowered their price target on the stock from $34.00 to $27.00. The stock had previously closed at $17.48, but opened at $16.72. BMO Capital Markets currently has an outperform rating on the stock. Chemours shares last traded at $17.16, with a volume of 145,724 shares changing hands.
Other analysts also recently issued research reports about the company. Truist Financial assumed coverage on Chemours in a research report on Tuesday, January 28th. They issued a “buy” rating and a $27.00 target price on the stock. Mizuho lowered their target price on Chemours from $22.00 to $21.00 and set a “neutral” rating on the stock in a research report on Tuesday, January 7th. Royal Bank of Canada reaffirmed an “outperform” rating and issued a $25.00 target price on shares of Chemours in a research report on Thursday, December 12th. Barclays boosted their price target on Chemours from $21.00 to $23.00 and gave the stock an “equal weight” rating in a research report on Tuesday, November 5th. Finally, The Goldman Sachs Group lowered their price target on Chemours from $24.00 to $21.00 and set a “neutral” rating on the stock in a research report on Tuesday, January 7th. Five equities research analysts have rated the stock with a hold rating and four have issued a buy rating to the company’s stock. According to data from MarketBeat.com, Chemours has an average rating of “Hold” and an average target price of $23.56.
View Our Latest Stock Report on CC
Institutional Investors Weigh In On Chemours
Chemours Stock Performance
The firm has a market capitalization of $2.51 billion, a P/E ratio of 29.42 and a beta of 1.81. The company has a current ratio of 1.68, a quick ratio of 0.92 and a debt-to-equity ratio of 6.70. The company has a 50-day moving average of $18.13 and a 200-day moving average of $18.93.
Chemours (NYSE:CC – Get Free Report) last announced its earnings results on Tuesday, February 18th. The specialty chemicals company reported $0.11 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.10 by $0.01. Chemours had a return on equity of 26.54% and a net margin of 1.51%. The business had revenue of $1.36 billion during the quarter, compared to analyst estimates of $1.37 billion. On average, equities analysts anticipate that The Chemours Company will post 2.06 earnings per share for the current fiscal year.
Chemours Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Friday, March 14th. Stockholders of record on Friday, February 28th will be paid a $0.25 dividend. The ex-dividend date is Friday, February 28th. This represents a $1.00 annualized dividend and a dividend yield of 5.96%. Chemours’s dividend payout ratio is presently 175.44%.
About Chemours
The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging.
Featured Stories
- Five stocks we like better than Chemours
- How to Calculate Inflation Rate
- 3 Stocks Poised to Thrive as NVIDIA Dominates the AI Boom
- Top Biotech Stocks: Exploring Innovation Opportunities
- MercadoLibre: High-Growth EM Stock With 100% Upside Potential
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- As the Magnificent 7 Stalls, These 3 Stocks Are Gaining Momentum
Receive News & Ratings for Chemours Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemours and related companies with MarketBeat.com's FREE daily email newsletter.